Daiken Biomedical Co., Ltd. (TPE:7780)
18.00
-0.35 (-1.91%)
At close: May 14, 2026
16.50% (1Y)
| Market Cap | 14.50B +54.4% |
| Revenue (ttm) | 2.02B +39.0% |
| Net Income | 337.22M +39.0% |
| EPS | 0.42 -8.6% |
| Shares Out | 810.02M |
| PE Ratio | 43.00 |
| Forward PE | 23.71 |
| Dividend | 0.70 (3.88%) |
| Ex-Dividend Date | Nov 24, 2025 |
| Volume | 1,706,348 |
| Average Volume | 2,385,827 |
| Open | 18.35 |
| Previous Close | 18.35 |
| Day's Range | 18.00 - 18.40 |
| 52-Week Range | 15.40 - 40.10 |
| Beta | n/a |
| RSI | 35.37 |
| Earnings Date | May 15, 2026 |